English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/173947
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Complement component 3: a new paradigm in tuberculosis vaccine

AuthorsFuente, José de la ; Gortázar, Christian ; Juste, Ramón A.
KeywordsMycobacteria
Vaccine
Immunology
Complement
Tuberculosis
Issue Date2016
PublisherTaylor & Francis
CitationExpert Review of Vaccines 15(3): 275-277 (2016)
AbstractVaccines are critical for the control of tuberculosis (TB) affecting humans and animals worldwide. First-generation vaccines protect from active TB but new vaccines are required to protect against pulmonary disease and infection. Recent advances in post-genomics technologies have allowed the characterization of host-pathogen interactions to discover new protective antigens and mechanisms to develop more effective vaccines against TB. Studies in the wild boar model resulted in the identification of complement component 3 (C3) as a natural correlate of protection against TB. Oral immunization with heat-inactivated mycobacteria protected wild boar against TB and showed that C3 plays a central role in protection. These results point at C3 as a target to develop novel vaccine formulations for more effective protection against TB in humans and animals.
URIhttp://hdl.handle.net/10261/173947
Identifiersdoi: 10.1586/14760584.2016.1125294
e-issn: 1744-8395
issn: 1476-0584
Appears in Collections:(IREC) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.